Neural Compromise: Causes, Consequences, and Multidisciplinary Management

Neural compromise denotes any structural or functional disruption of the nervous system (CNS/PNS) leading to neurological deficit. It is a clinical syndrome, not a specific diagnosis.

Major Etiologic Categories

Category	Examples	Mechanism
Traumatic	TBI, SCI, peripheral nerve injury, compressive neuropathy	Mechanical disruption, shear, ischemia, edema
Vascular	Ischemic/hemorrhagic stroke, SAH, vascular malformation, vasculitis	Infarction, hemorrhage, mass effect
Degenerative	Alzheimer's, Parkinson's, ALS, FTD, Huntington's, MSA, PSP	Proteinopathy, neuronal loss, circuit failure
Demyelinating/Inflammatory	MS, NMOSD, ADEM, GBS, CIDP, autoimmune encephalitis	Immune-mediated myelin/axon injury
Infectious	Meningitis, encephalitis, abscess, TB, neurocysticercosis, HIV, PML	Direct invasion, inflammation, infarct
Neoplastic	Primary (glioma, meningioma), metastatic, paraneoplastic	Mass effect, infiltration, remote effects
Metabolic/Toxic	B12 deficiency, Wernicke's, hepatic/uremic encephalopathy, heavy metals, chemo-neurotoxicity, alcohol	Neuronal dysfunction/death from metabolic derangement
Congenital/Developmental	Neural tube defects, cortical malformations, leukodystrophies, mitochondrial disorders	Abnormal formation/maintenance

Functional Domains Affected

• Motor: Weakness, spasticity, ataxia, apraxia, movement disorders.
• Sensory: Numbness, pain, paresthesia, vision/hearing loss.
• Cognitive: Memory, executive, language, attention, social cognition.
• Autonomic: BP/HR lability, bladder/bowel/sexual dysfunction, thermoregulation.
• Consciousness: Coma, delirium, vegetative/minimally conscious states.

Management Framework

1. Acute stabilization: ABCs, ICP control, reperfusion (stroke), decompression (SCI), antidotes.
2. Etiologic treatment: Immunotherapy, antimicrobials, tumor resection, metabolic correction.
3. Neurorehabilitation: PT/OT/SLP, cognitive rehab, neuropsychology, assistive tech, spasticity management.
4. Neuroprotection / Disease modification: DMTs (MS), symptomatic meds (PD, ALS), clinical trials.
5. Palliative / Advance care: Goals of care, QoL, caregiver support.

Neural compromise demands rapid, coordinated, subspecialty care. Time is brain (and cord).